• Adagene to Host Virtual KOL Event to Discuss Anti-CTLA-4 SAFEbody® ADG126 1/21/2025
• Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG12... 10/10/2024
• Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential fo... 9/18/2024
• Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug... 1/5/2024
• Adagene Appoints Cuong Do to Board of Directors and Audit Committee 11/22/2022
• Adagene Announces Poster Presentations on Anti-CTLA-4 NEObody™, ADG116 10/12/2022
• Adagene Presents Interim Monotherapy Data at ESMO 2022 9/13/2022